- Home
- RCEL vs BMN Comparison
RCEL vs BMN Comparison
Compare RCEL & BMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCEL
- BMN
- Stock Information
- Founded
- RCEL N/A
- BMN 2020
- Country
- RCEL United States
- BMN United States
- Employees
- RCEL N/A
- BMN 19800
- Industry
- RCEL Medical/Dental Instruments
- BMN Trusts Except Educational Religious and Charitable
- Sector
- RCEL Health Care
- BMN Finance
- Exchange
- RCEL Nasdaq
- BMN Nasdaq
- Market Cap
- RCEL 170.8M
- BMN 146.9M
- IPO Year
- RCEL N/A
- BMN N/A
- Fundamental
- Price
- RCEL $5.62
- BMN $24.24
- Analyst Decision
- RCEL Strong Buy
- BMN
- Analyst Count
- RCEL 4
- BMN 0
- Target Price
- RCEL $17.25
- BMN N/A
- AVG Volume (30 Days)
- RCEL 347.9K
- BMN 29.9K
- Earning Date
- RCEL 05-08-2025
- BMN 01-01-0001
- Dividend Yield
- RCEL N/A
- BMN 4.66%
- EPS Growth
- RCEL N/A
- BMN N/A
- EPS
- RCEL N/A
- BMN N/A
- Revenue
- RCEL $71,661,000.00
- BMN N/A
- Revenue This Year
- RCEL $59.50
- BMN N/A
- Revenue Next Year
- RCEL $28.89
- BMN N/A
- P/E Ratio
- RCEL N/A
- BMN N/A
- Revenue Growth
- RCEL 41.35
- BMN N/A
- 52 Week Low
- RCEL $5.46
- BMN $21.51
- 52 Week High
- RCEL $14.16
- BMN $25.59
- Technical
- Relative Strength Index (RSI)
- RCEL 25.54
- BMN 55.20
- Support Level
- RCEL $6.06
- BMN $23.97
- Resistance Level
- RCEL $6.38
- BMN $24.56
- Average True Range (ATR)
- RCEL 0.47
- BMN 0.38
- MACD
- RCEL -0.11
- BMN 0.04
- Stochastic Oscillator
- RCEL 8.12
- BMN 43.31
About RCEL Avita Medical Inc.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
About BMN BlackRock 2037 Municipal Target Term Trust of Beneficial Interest
BlackRock 2037 Mun Tgt is a non-diversified, closed-end management investment company. The Trust's investment objective is to provide current income that is exempt from regular federal income tax. The Trust invests in investment grade quality securities or securities that are unrated but judged to be of comparable quality by the investment adviser.